ENZON PHARMACEUTICALS INC's ticker is ENZN and the CUSIP is 293904108. A total of 48 filers reported holding ENZON PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $1,477,000 | -38.2% | 3,143,585 | -10.2% | 0.00% | -40.0% |
| Q4 2015 | $2,390,000 | -30.4% | 3,501,585 | -1.1% | 0.01% | -37.5% |
| Q3 2015 | $3,434,000 | -20.8% | 3,540,084 | -2.1% | 0.01% | -20.0% |
| Q2 2015 | $4,338,000 | +87.2% | 3,614,909 | +65.4% | 0.01% | +100.0% |
| Q1 2015 | $2,317,000 | +17.7% | 2,185,907 | +21.0% | 0.01% | 0.0% |
| Q4 2014 | $1,969,000 | +15.9% | 1,806,684 | +14.8% | 0.01% | 0.0% |
| Q3 2014 | $1,699,000 | +46.1% | 1,573,384 | +40.7% | 0.01% | +66.7% |
| Q2 2014 | $1,163,000 | +16.2% | 1,118,184 | +15.0% | 0.00% | +50.0% |
| Q1 2014 | $1,001,000 | +12.7% | 971,984 | +27.0% | 0.00% | 0.0% |
| Q4 2013 | $888,000 | -35.6% | 765,284 | -6.7% | 0.00% | -33.3% |
| Q3 2013 | $1,378,000 | -24.3% | 819,984 | -9.9% | 0.00% | -40.0% |
| Q2 2013 | $1,821,000 | – | 910,308 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|